Version 2.77

Part Descriptions

LP14839-2   Plasmodium falciparum
Four species of the Plasmodium protozoa are considered true parasites of humans as they use humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Malaria today is usually restricted to tropical and subtropical areas and altitudes below 1,500 m., although in the past malaria was endemic in much of North America, Europe and even parts of northern Asia, and today is still present on the Korean peninsula. However, this present distribution could be affected by climatic changes and population movements. P. falciparum is the most prevalent species and responsible for the most morbidity and mortality worldwide. Early detect is of paramount importance due to the incidence of cerebral malaria and drug resistance. Malarial infections caused by P. falciparum are the most likely to progress to severe, potentially fatal forms with central nervous system involvement (cerebral malaria), acute renal failure, severe anemia, or acute respiratory distress syndrome.[CDC] Source: Regenstrief LOINC, CDC

LP20149-8   Plasmodium
Malaria is a parasitic disease that is passed from one human to another by the bite of an infected Anopheles mosquito with one of four protozoan parasites: Plasmodium falciparum, vivax, malariae or ovale. The parasites enter the bloodstream and infect red blood cells where they multiply and infect more red blood cells. Symptoms usually occur 10 days to 4 weeks after infection and include anemia, high fevers, shaking chills, muscle pain, and nausea. Antimalarial agents used to treat malaria include Quinine, Quinidine, Mefloquine, Chloroquine, and Hydroxychloroquine. The effectiveness of the agents depends on which phase or phases of the Plasmodium life cycle is interrupted. In most cases, treatment outcome is expected to be good except in cases of a p. falciparum infection. Adverse effects from antimalaria medications include vomiting, diarrhea, headaches, cardiac arrhythmias, EKG abnormalities, deafness, damage to liver and kidney and muscle weakness. Source: NMS labs

Fully-Specified Name

Component
Plasmodium falciparum Ab.IgM
Property
PrThr
Time
Pt
System
Ser
Scale
Ord
Method
IA

Additional Names

Short Name
P falciparum IgM Ser Ql IA
Display Name
P. falciparum IgM IA Ql (S)
Consumer Name Alpha Get Info
Plasmodium falciparum IgM antibody, Blood

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.29
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG41640-0 Plasmodium

Language Variants Get Info

Tag Language Translation
de-DE German (Germany) Plasmodium falciparum Ak.IgM:Nachweis oder Schwellenwert:Zeitpunkt:Serum:Ordinal:Immunoassay
es-ES Spanish (Spain) Plasmodium falciparum IgM:PrThr:Punto temporal:Suero:Ord:IA
es-MX Spanish (Mexico) Plasmodium falciparum Ab.IgM:Presencia o umbral:Punto temporal:Suero:Ordinal:Inmunoensayo
et-EE Estonian (Estonia) Plasmodium falciparum antikehad.IgM:PrThr:Pt:S:Ord:IA
Synonyms: Immuunglobuliin M Järgarvuline Juhuslik Seerum
fr-CA French (Canada) Plasmodium falciparum , IgM:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:IA
fr-FR French (France) Plasmodium falciparum Ac IgM:Présence/Seuil:Ponctuel:Sérum:Qualitatif:Immunoanalyse
fr-BE French (Belgium) Plasmodium falciparum Anticorps. IgM:PrThr:Temps ponctuel:Sérum:Ordinal:IA
Synonyms: Anticorps
it-IT Italian (Italy) Plasmodium falciparum Ab.IgM:PrThr:Pt:Siero:Ord:IA
Synonyms: Anticorpi IgM anticorpo Immunoassay Microbiologia Presenza o Soglia Punto nel tempo (episodio) Siero
nl-NL Dutch (Netherlands) Plasmodium falciparum As.IgM:aanwezigheid:moment:serum:ordinaal:immunoassay
Synonyms: antistof; antilichaam IA
pl-PL Polish (Poland) Plasmodium falciparum Ab.IgM:granica wykrywalności:punkt w czasie:surowica:półilościowy:metoda immunologiczna
Synonyms: IgM Plasmodium falciparum Przeciwciała do Plasmodium falciparum Przeciwciała IgM do Plasmodium falciparum
pt-BR Portuguese (Brazil) Plasmodium falciparum Ac.IgM:#N/A:Pt:Soro:Ord:Imunoensaio
Synonyms: ; P falciparum; Immune globulin M; Immunoglobulin M; Arbitrary concentration; Point in time; Random; Serum; SR; Ql; Ordinal; QL; Qualitative; Qual; Screen; Enzyme immunoassay; ELISA; MEIA; SUDS; ELFA; IAA; Antibodies; Autoantibody; Antibody; Autoantibodies; Antby; Acy; Anti; Malarial; Malaria; Microbiology
ru-RU Russian (Russian Federation) Plasmodium falciparum Ат.IgM:PrThr:ТчкВрм:Сыв:Пор:IA
Synonyms: Антитело Порядковый Сыворотка Точка во времени;Момент
tr-TR Turkish (Turkey) Plasmodium falciparum Ab.IgM:MevcEşik:Zmlı:Ser:Srl:İA
Synonyms: Ak Ak.IgM İmmünölçüm, immünoassay Mevcut
zh-CN Chinese (China) 恶性疟原虫 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法
Synonyms: Ab.IgM;IgM;抗体 IgM Ab;自身抗体 依次型;分类顺序型;定性的;序数型(或称等级型);性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 免疫球蛋白 M 原形体 原质团 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况(存在、存在与否、是否存在)或阈值(界值、界限、阀值、临界值) 微生物学;微生物学试验;微生物学试验(培养、DNA、抗原及抗体) 恶性疟;热带疟原虫 恶性疟原虫 Ab 时刻;随机;随意;瞬间 疟 疟原虫 疟疾 疟病 瘴气

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=57683-5